Advaxis Inc (OTCMKTS:ADXS) Stock On Radar After Q3 Earnings
Clinical stage biotech company Advaxis Inc (OTCMKTS:ADXS) could be one of the companies that could be in focus among investors today after it announced its financial results for the third quarter that ended on July 31, 2022 yesterday. Trading Data On Monday, ADXS stock increased 0.33% to $3.0600 with 1.06K shares, compared to its average volume 4.26K shares. The stock moved within a range of $3.0600 – 3.4700 after opening…